188 related articles for article (PubMed ID: 11231645)
21. [Comparison of outcome of primary PTCA for acute myocardial infarction in patients younger and older than 70 years of age].
Santoro GM; Valenti R; Buonamici P; Cerisano G; Bolognese L; Antoniucci D; Fazzini PF
G Ital Cardiol; 1996 Oct; 26(10):1111-22. PubMed ID: 9005157
[TBL] [Abstract][Full Text] [Related]
22. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.
Montalescot G; Barragan P; Wittenberg O; Ecollan P; Elhadad S; Villain P; Boulenc JM; Morice MC; Maillard L; Pansiéri M; Choussat R; Pinton P;
N Engl J Med; 2001 Jun; 344(25):1895-903. PubMed ID: 11419426
[TBL] [Abstract][Full Text] [Related]
23. Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients.
Kunadian B; Vijayalakshmi K; Dunning J; Thornley AR; Sutton AG; Muir DF; Wright RA; Hall JA; de Belder MA
J Invasive Cardiol; 2007 May; 19(5):217-23. PubMed ID: 17476036
[TBL] [Abstract][Full Text] [Related]
24. Predictors of and outcomes of early thrombosis following balloon angioplasty versus primary stenting in acute myocardial infarction and usefulness of abciximab (the CADILLAC trial).
Dangas G; Aymong ED; Mehran R; Tcheng JE; Grines CL; Cox DA; Garcia E; Griffin JJ; Guagliumi G; Stuckey T; Lansky AJ; Stone GW;
Am J Cardiol; 2004 Oct; 94(8):983-8. PubMed ID: 15476608
[TBL] [Abstract][Full Text] [Related]
25. Incidence, consequences, and risk factors of early reocclusion after primary and/or rescue percutaneous transluminal coronary angioplasty for acute myocardial infarction.
Garot P; Himbert D; Juliard JM; Golmard JL; Steg PG
Am J Cardiol; 1998 Sep; 82(5):554-8. PubMed ID: 9732878
[TBL] [Abstract][Full Text] [Related]
26. Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial).
Stuckey TD; Stone GW; Cox DA; Tcheng JE; Garcia E; Carroll J; Guagliumi G; Rutherford BD; Griffin JJ; Turco M; Lansky AJ; Mehran R; Fahy M; Brodie BR; Grines CL;
Am J Cardiol; 2005 Jan; 95(1):1-7. PubMed ID: 15619385
[TBL] [Abstract][Full Text] [Related]
27. Survival after early surgical revascularization in patients with both acute myocardial infarction and cardiogenic shock.
Hsu RB; Chien CY; Wang SS; Chu SH
J Formos Med Assoc; 2001 Nov; 100(11):725-8. PubMed ID: 11802529
[TBL] [Abstract][Full Text] [Related]
28. Predictors of mortality at 30 days in high-risk patients treated with direct or rescue stenting for acute myocardial infarction: a single center experience.
La Vecchia L; Martini M; Sartori M; Vincenzi P; Cischele L; Righetti T; Ometto R; Fontanelli A
J Invasive Cardiol; 2001 Oct; 13(10):689-93. PubMed ID: 11581511
[TBL] [Abstract][Full Text] [Related]
29. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Guagliumi G; Stone GW; Cox DA; Stuckey T; Tcheng JE; Turco M; Musumeci G; Griffin JJ; Lansky AJ; Mehran R; Grines CL; Garcia E
Circulation; 2004 Sep; 110(12):1598-604. PubMed ID: 15353506
[TBL] [Abstract][Full Text] [Related]
30. Routine upfront abciximab versus standard periprocedural therapy in patients undergoing primary percutaneous coronary intervention for cardiogenic shock: The PRAGUE-7 Study. An open randomized multicentre study.
Tousek P; Rokyta R; Tesarova J; Pudil R; Belohlavek J; Stasek J; Rohac F; Widimsky P
Acute Card Care; 2011 Sep; 13(3):116-22. PubMed ID: 21526919
[TBL] [Abstract][Full Text] [Related]
31. Impact of abciximab on prognosis in diabetic patients undergoing primary percutaneous coronary intervention.
Perkan A; Vitrella G; Barbati G; De Monte A; D'Agata B; Merlo M; Giannini F; Della Grazia E; Rakar S; Salvi A; Igidbashian D; Morgera T; Zalukar W; Sinagra G
J Cardiovasc Med (Hagerstown); 2013 Feb; 14(2):127-35. PubMed ID: 22343257
[TBL] [Abstract][Full Text] [Related]
32. Frequency and efficacy of glycoprotein IIb/IIIa therapy for treatment of threatened or acute vessel closure in 1332 patients undergoing percutaneous transluminal coronary angioplasty.
Haase KK; Mahrholdt H; Schröder S; Baumbach A; Oberhoff M; Herdeg C; Karsch KR
Am Heart J; 1999 Feb; 137(2):234-40. PubMed ID: 9924156
[TBL] [Abstract][Full Text] [Related]
33. Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial).
Maioli M; Bellandi F; Leoncini M; Toso A; Dabizzi RP
J Am Coll Cardiol; 2007 Apr; 49(14):1517-24. PubMed ID: 17418289
[TBL] [Abstract][Full Text] [Related]
34. Early administration of abciximab in patients with acute myocardial infarction improves angiographic and clinical outcome after primary angioplasty.
Beeres SL; Oemrawsingh PV; Warda HM; Bechan R; Atsma DE; Jukema JW; van der Wall EE; Schalij MJ
Catheter Cardiovasc Interv; 2005 Aug; 65(4):478-83. PubMed ID: 15973655
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of primary coronary angioplasty and angioplasty after initial thrombolysis in the treatment of 374 consecutive patients with acute myocardial infarction.
Poloński L; Gasior M; Wasilewski J; Wilczek K; Wnek A; Adamowicz-Czoch E; Sikora J; Lekston A; Zebik T; Gierlotka M; Wojnar R; Szkodziński J; Kondys M; Szyguła-Jurkiewicz B; Wołk R; Zembala M
Am Heart J; 2003 May; 145(5):855-61. PubMed ID: 12766744
[TBL] [Abstract][Full Text] [Related]
36. Impact of ST-segment resolution after primary angioplasty on outcomes after myocardial infarction in elderly patients: an analysis from the CADILLAC trial.
Prasad A; Stone GW; Aymong E; Zimetbaum PJ; McLaughlin M; Mehran R; Garcia E; Tcheng JE; Cox DA; Grines CL; Gersh BJ;
Am Heart J; 2004 Apr; 147(4):669-75. PubMed ID: 15077083
[TBL] [Abstract][Full Text] [Related]
37. Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Lansky AJ; Pietras C; Costa RA; Tsuchiya Y; Brodie BR; Cox DA; Aymong ED; Stuckey TD; Garcia E; Tcheng JE; Mehran R; Negoita M; Fahy M; Cristea E; Turco M; Leon MB; Grines CL; Stone GW
Circulation; 2005 Apr; 111(13):1611-8. PubMed ID: 15811868
[TBL] [Abstract][Full Text] [Related]
38. [Direct percutaneous transluminal coronary angioplasty in patients with acute myocardial infarct treated at the Cardiac Center of the General Medical School Hospital in Prague: a 1-year retrospective study].
Holm F; Kovárník T; Aschermann M; Simek S; Linhart A; Humhal J; Skulec R; Reznícek V
Vnitr Lek; 2002 May; 48(5):373-9. PubMed ID: 12061202
[TBL] [Abstract][Full Text] [Related]
39. [Interventional treatment of acute myocardial infarct].
Straumann E; Naegeli B; Frielingsdorf J; Gerber A; Mury R; Schuiki E; Bertel O
Schweiz Med Wochenschr; 2000 Dec; 130(51-52):1970-8. PubMed ID: 11688064
[TBL] [Abstract][Full Text] [Related]
40. [PTCA in the acute state of myocardial infarct: hospital course of 785 consecutive patients].
Heintzen MP; Motz W; Leschke M; Schultheiss HP; Horstkotte D; Vester EG; Wahbe L; Ries T; Pütz H; Sommer P
Z Kardiol; 1994 Jun; 83(6):404-13. PubMed ID: 8067043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
